Holen Sie sich die Stockscreener-App
2.12
2.08%
-0.045
Handel nachbörslich:
2.18
0.06
+2.83%
Schlusskurs vom Vortag:
$2.165
Offen:
$2.13
24-Stunden-Volumen:
55,024
Relative Volume:
0.04
Marktkapitalisierung:
$22.07M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-45.57M
KGV:
-0.3365
EPS:
-6.3
Netto-Cashflow:
$-38.56M
1W Leistung:
+5.47%
1M Leistung:
-16.86%
6M Leistung:
+25.44%
1J Leistung:
-15.76%
1-Tages-Spanne:
$2.12
$2.185
1-Wochen-Bereich:
$1.9801
$2.29
52-Wochen-Spanne:
$1.00
$6.60
Sab Biotherapeutics Inc Stock (SABS) Company Profile
Firmenname
Sab Biotherapeutics Inc
Sektor
Branche
Telefon
305-845-2813
Adresse
777 W 41ST ST, MIAMI BEACH
Vergleichen Sie SABS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SABS
Sab Biotherapeutics Inc
|
2.12 | 20.57M | 0 | -45.57M | -38.56M | -6.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.72B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 60.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 58.15B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 41.45B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Sab Biotherapeutics Inc Stock (SABS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-14 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-10-09 | Eingeleitet | Craig Hallum | Buy |
| 2024-08-28 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-05 | Eingeleitet | Chardan Capital Markets | Buy |
Sab Biotherapeutics Inc Aktie (SABS) Neueste Nachrichten
SAB Biotherapeutics Inc. stock trendline breakdown2025 Short Interest & Fast Gaining Stock Reports - Newser
SAB Biotherapeutics Inc. stock momentum explained2025 Short Interest & Stepwise Trade Signal Guides - Newser
SAB Biotherapeutics Inc. Equity Warrant stock trend forecast2025 Winners & Losers & Real-Time Volume Trigger Notifications - Newser
Published on: 2025-08-27 11:17:14 - Newser
What the charts say about SAB Biotherapeutics Inc. todayBear Alert & Comprehensive Market Scan Reports - Newser
What machine learning models say about SAB Biotherapeutics Inc.Portfolio Profit Report & Free Community Consensus Stock Picks - Newser
How to integrate SAB Biotherapeutics Inc. Equity Warrant into portfolio analysis toolsJuly 2025 PreEarnings & Real-Time Buy Zone Alerts - Newser
Risk adjusted return profile for SAB Biotherapeutics Inc. Equity Warrant analyzedTrade Risk Report & Free High Return Stock Watch Alerts - Newser
Using economic indicators to assess SAB Biotherapeutics Inc. potentialTrend Reversal & Weekly High Conviction Ideas - Newser
SAB Biotherapeutics Inc. stock chart pattern explainedPortfolio Performance Report & Low Drawdown Momentum Trade Ideas - Newser
Can SAB Biotherapeutics Inc. Regain Lost Ground This Quarter getLinesFromResByArray error: size == 0 - newsyoung.net
Analyzing recovery setups for SAB Biotherapeutics Inc. Equity Warrant investorsJobs Report & Weekly Consistent Profit Watchlists - Newser
Is it time to cut losses on SAB Biotherapeutics Inc.Swing Trade & Reliable Volume Spike Alerts - Newser
Applying sector rotation models to SAB Biotherapeutics Inc.Earnings Beat & Risk Managed Investment Entry Signals - Newser
SAB Biotherapeutics Inc. Equity Warrant stock chart pattern explainedTrade Volume Summary & Entry Point Confirmation Signals - Newser
What indicators show strength in SAB Biotherapeutics Inc.Quarterly Earnings Report & Expert Curated Trade Ideas - Newser
Pattern recognition hints at SAB Biotherapeutics Inc. upsideEntry Point & Precise Buy Zone Identification - Newser
Using economic indicators to assess SAB Biotherapeutics Inc. Equity Warrant potential2025 Technical Overview & Stepwise Swing Trade Plans - Newser
Sentiment analysis tools applied to SAB Biotherapeutics Inc.M&A Rumor & Consistent Growth Stock Picks - Newser
Chart overlay techniques for tracking SAB Biotherapeutics Inc. Equity WarrantWeekly Market Outlook & Precise Buy Zone Tips - Newser
Multi asset correlation models including SAB Biotherapeutics Inc.Options Play & Free Community Supported Trade Ideas - Newser
Is now a turning point for SAB Biotherapeutics Inc.Treasury Yields & Free Real-Time Volume Trigger Notifications - Newser
Using portfolio simulators with SAB Biotherapeutics Inc. includedJuly 2025 Sentiment & Stepwise Trade Execution Plans - Newser
Analyzing SAB Biotherapeutics Inc. with multi timeframe chartsMarket Growth Summary & Free Low Drawdown Momentum Trade Ideas - Newser
Real time breakdown of SAB Biotherapeutics Inc. stock performanceWeekly Profit Recap & Pattern Based Trade Signal System - Newser
Key metrics from SAB Biotherapeutics Inc.’s quarterly dataPortfolio Profit Report & AI Enhanced Trading Alerts - Newser
How sentiment analysis helps forecast SAB Biotherapeutics Inc.Breakout Watch & High Return Trade Guides - Newser
Is SAB Biotherapeutics Inc. Forming a Bottom PatternTrade Volume Summary & Risk Controlled Daily Plans - 더경남뉴스
What is SAB Biotherapeutics Inc. Equity Warrant’s TAM (Total Addressable Market)July 2025 Sentiment & Reliable Breakout Stock Forecasts - sundaytimes.kr
SAB Biotherapeutics Inc. Recovery Linked to Earnings SurpriseWeekly Stock Analysis & Reliable Breakout Stock Forecasts - 클래시안
Will SAB Biotherapeutics Inc. Equity Warrant continue its uptrendWeekly Stock Report & Daily Profit Maximizing Tips - Newser
Can SAB Biotherapeutics Inc. hit a new high this monthWeekly Trend Recap & Verified Stock Trade Ideas - Newser
Earnings Recap: Is SAB Biotherapeutics Inc. stock overvalued or fairly priced2025 Pullback Review & Weekly Sector Rotation Insights - sundaytimes.kr
Heatmap Data Shows High Activity in SAB Biotherapeutics Inc. SectorWeekly Stock Recap & Capital Efficient Trade Techniques - 더경남뉴스
Automated trading signals detected on SAB Biotherapeutics Inc. Equity Warrant - Newser
SAB Biotherapeutics Inc.’s Beta Climbs After Market VolatilityPortfolio Update Report & Community Verified Trade Signals - beatles.ru
Reversal Confirmed SAB Biotherapeutics Inc. Equity Warrant Stock Rallies Above MAGold Moves & Fast Entry Momentum Alerts - beatles.ru
Momentum Shift: What is the next catalyst for SAB Biotherapeutics Inc.Portfolio Return Report & Fast Moving Market Watchlists - sundaytimes.kr
Published on: 2025-08-21 20:27:18 - beatles.ru
Finanzdaten der Sab Biotherapeutics Inc-Aktie (SABS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
8.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):